Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Star Sports Medicine CoHKSE:01609 -0.21%20 ROA % is 26.24% as of Dec. 2025, which is 65% above its 10-year median of 15.93. GuruFocus rates HKSE:01609 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review. Among 853 Medical Devices & Instruments companies, Star Sports Medicine Co ranks better than 67.17% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Star Sports Medicine Co's annualizedNet Income for the quarter that ended in Dec. 2025 was HK$208.1 Mil.
Star Sports Medicine Co's average Total Assets over the quarter that ended in Dec. 2025 was HK$793.2 Mil. Therefore, Star Sports Medicine Co's annualized ROA % for the quarter that ended in Dec. 2025 was 26.24%.
The historical rank and industry rank for Star Sports Medicine Co's ROA % or its related term are showing as below:
HKSE:01609'
s ROA % Range Over the Past 10 Years
Min: 4.81 Med: 15.93 Max: 20.13
Current: 4.81
During the past 4 years, Star Sports Medicine Co's highest ROA % was 20.13%. The lowest was 4.81%. And the median was 15.93%.
HKSE:01609's ROA % is ranked better than 67.17% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 0.74
vs HKSE:01609: 4.81
Star Sports Medicine Co (HKSE:01609) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Star Sports Medicine Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Sports Medicine Co ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Star Sports Medicine Co's ROA % distribution charts can be found below:
* The bar in red indicates where Star Sports Medicine Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Star Sports Medicine Co (HKSE:01609) has a ROA % of 26.24% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Star Sports Medicine Co and its competitors. This is 65% above median its historical median of 15.93. Over the past decade, Star Sports Medicine Co's ROA % has ranged from 4.81 to 20.13. According to the industry distribution chart, Star Sports Medicine Co ranks #280 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 32.8%.
Is Star Sports Medicine Co's ROA % too high?
Star Sports Medicine Co's current ROA % of 26.24% is 65% above median its 10-year median of 15.93. Over the past 10 years, this metric has ranged from a low of 4.81 to a high of 20.13. The Medical Devices & Instruments industry median ROA % is 0.74. Star Sports Medicine Co's value of 26.24% is 3445.9% above this industry median. Based on the distribution chart, Star Sports Medicine Co ranks #280 out of 853 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Star Sports Medicine Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Star Sports Medicine Co's ROA % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Star Sports Medicine Co ranks #280 out of 853 companies for ROA %. This puts Star Sports Medicine Co in the upper half of its industry. The industry median ROA % is 0.74. Star Sports Medicine Co's value of 26.24% is 3445.9% above this benchmark. Historically, Star Sports Medicine Co's own ROA % has ranged from 4.81 to 20.13 over the past decade. While the company's 10-year median is 15.93 vs. the industry median of 0.74, Star Sports Medicine Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.74, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Star Sports Medicine Co's current ROA % of 26.24% is 3445.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Star Sports Medicine Co and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Star Sports Medicine Co's current ROA % is 26.24%, which is 65% above median its own 10-year median of 15.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Sports Medicine Co stock overvalued right now?
Star Sports Medicine Co (HKSE:01609) has a current ROA % of 26.24%. The current ROA % is 26.24%, which is 65% above median its 10-year median of 15.93 and 3445.9% above the Medical Devices & Instruments industry median of 0.74. Star Sports Medicine Co's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Star Sports Medicine Co (HKSE:01609), the current ROA % is 26.24% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Star Sports Medicine Co Ltd is a China-based medical device company specializing in clinical sports medicine solutions. It is principally engaged in the research and development and sales of medical devices and equipment in the field of sports medicine. The product line covers medical implants, surgical equipment and associated medical consumables. The company has only one reportable operating segment, which is the sale of sports medicine products. It derives revenue from the sales of (i) medical implants and (ii) surgical equipment and associated medical consumables, with the majority of revenue generated from the sales of Medical implants. Geographically, the maximum revenue is derived from the Chinese mainland.
20GF Score
Get the complete analysis for HKSE:01609
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01609 has been successfully added to your 
